Jeffrey Ludwig
Corporate Officer/Principal at PUMA BIOTECHNOLOGY, INC.
Net worth: 673 296 $ as of 2024-03-30
Profile
Jeffrey Ludwig is currently the Chief Commercial Officer at Puma Biotechnology, Inc. Prior to this, he was the Vice President-Oncology Sales at Amgen, Inc. from 2014 to 2019 and at Astellas Pharma, Inc. from 2019 to 2020.
He completed his undergraduate degree at Arizona State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC.
0.26% | 2024-02-11 | 127,037 ( 0.26% ) | 673 296 $ | 2024-03-30 |
Jeffrey Ludwig active positions
| Companies | Position | Start |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 2020-02-29 |
Former positions of Jeffrey Ludwig
| Companies | Position | End |
|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 2019-12-31 |
| AMGEN INC. | Corporate Officer/Principal | 2018-12-31 |
Training of Jeffrey Ludwig
| Arizona State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ASTELLAS PHARMA INC. | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Ludwig
